Recent News
View All
February 27th, 2023
Entrada Therapeutics to Participate in Cowen 43rd Annual Health Care Conference
Our Mission
At Entrada, we are united in our mission to treat devastating diseases with intracellular therapeutics.
Our Platform
Our proprietary EEV™ Platform has the potential to reach and engage previously inaccessible and undruggable disease-causing targets within cells.
Our Pipeline
Our EEV™ Platform is highly versatile and modular, offering broad potential across therapeutic areas. We are already developing potential treatments across multiple devastating diseases, and this is just the beginning.
Life at Entrada
Join our team if you share our values, our devotion to patients and our passion for science.